Impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein (SYNCHRONOUS-Study): study protocol for a prospective, multicentre, controlled observational study

Introduction To date, there are no prospective studies evaluating the prevention of recurrent veins by the simultaneous treatment of a sufficient anterior accessory saphenous vein (AASV) in patients undergoing endovenous laser ablation (EVLA) of an insufficient great saphenous vein (GSV). This study...

Full description

Saved in:
Bibliographic Details
Main Authors: Lorenz Uhlmann, Christine Fink, Karsten Hartmann, Thomas Mattausch, Hans-Christian Wenzel, Phillip Zollmann, Jürgen Veltman, Thomas Weiler, Guido Lengfellner, Lars Müller, Markus Stücker, Felizitas Pannier, Carmen Dietrich, Tobias Hirsch
Format: Article
Language:English
Published: BMJ Publishing Group 2022-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/6/e061530.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583961492062208
author Lorenz Uhlmann
Christine Fink
Karsten Hartmann
Thomas Mattausch
Hans-Christian Wenzel
Phillip Zollmann
Jürgen Veltman
Thomas Weiler
Guido Lengfellner
Lars Müller
Markus Stücker
Felizitas Pannier
Carmen Dietrich
Tobias Hirsch
author_facet Lorenz Uhlmann
Christine Fink
Karsten Hartmann
Thomas Mattausch
Hans-Christian Wenzel
Phillip Zollmann
Jürgen Veltman
Thomas Weiler
Guido Lengfellner
Lars Müller
Markus Stücker
Felizitas Pannier
Carmen Dietrich
Tobias Hirsch
author_sort Lorenz Uhlmann
collection DOAJ
description Introduction To date, there are no prospective studies evaluating the prevention of recurrent veins by the simultaneous treatment of a sufficient anterior accessory saphenous vein (AASV) in patients undergoing endovenous laser ablation (EVLA) of an insufficient great saphenous vein (GSV). This study will provide important information about the impact of the AASV on the development of recurrent veins after EVLA of the GSV. Additionally, it will be clarified whether patients benefit from a preventive ablation of a sufficient AASV.Methods and analysis This is a multicentre, prospective, controlled, exploratory clinical study in 1150 patients with a medical indication for EVLA of a refluxing great saphenous vein. Patients will be enrolled into two study groups: in half of the patients EVLA will be performed on the insufficient GSV only. In the other half of the patients EVLA will be performed on the insufficient GSV and additionally on the sufficient AASV. Within seven study visits, patients will be followed-up over a time period of 5 years. Primary study endpoint is the recurrence rate; secondary endpoints include inter alia, complication rate, postoperative pain intensity, quality of life and patient satisfaction.Ethics and dissemination Before initiation of the study, the protocol was presented and approved by the independent ethics committee of the medical faculty of the University of Heidelberg (Ethics approval number S-596/2018). This study was prospectively registered at the German Clinical Trial Register (https://www.germanctr.de/). Research findings will be disseminated in a peer-reviewed journal and at relevant conferences.Trial registration number German Clinical Trial Registry (DRKS00015486).
format Article
id doaj-art-1534ecca6a574e26a1adb6850523ae6c
institution Kabale University
issn 2044-6055
language English
publishDate 2022-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-1534ecca6a574e26a1adb6850523ae6c2025-01-27T23:40:12ZengBMJ Publishing GroupBMJ Open2044-60552022-06-0112610.1136/bmjopen-2022-061530Impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein (SYNCHRONOUS-Study): study protocol for a prospective, multicentre, controlled observational studyLorenz Uhlmann0Christine Fink1Karsten Hartmann2Thomas Mattausch3Hans-Christian Wenzel4Phillip Zollmann5Jürgen Veltman6Thomas Weiler7Guido Lengfellner8Lars Müller9Markus Stücker10Felizitas Pannier11Carmen Dietrich12Tobias Hirsch13Institute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, GermanyDepartment of Dermatology, University Hospital Heidelberg, Heidelberg, GermanyVenenzentrum Freiburg, Freiburg, GermanyVenenzentrum am Brühl, Leipzig, GermanyVenenzentrum am Brühl, Leipzig, GermanyMVZ Dr. Zollmann und Kollegen, Jena, GermanyMVZ Dr. Zollmann und Kollegen, Jena, GermanyVenenzentrum Pforzheim, Pforzheim, GermanyVenen-Fachpraxis Regensburg, Regensburg, GermanyDepartment of Vascular Surgery, Dermatologikum Hamburg, Hamburg, GermanyDepartment of Dermatology, Ruhr-Universität Bochum, Bochum, GermanyPraxis Dr. Pannier, Bonn, GermanyDepartment of Dermatology, University of Heidelberg, Heidelberg, GermanyPraxis für Innere Medizin und Gefäßkrankheiten, Venen Kompetenz-Zentrum, Halle (Saale), GermanyIntroduction To date, there are no prospective studies evaluating the prevention of recurrent veins by the simultaneous treatment of a sufficient anterior accessory saphenous vein (AASV) in patients undergoing endovenous laser ablation (EVLA) of an insufficient great saphenous vein (GSV). This study will provide important information about the impact of the AASV on the development of recurrent veins after EVLA of the GSV. Additionally, it will be clarified whether patients benefit from a preventive ablation of a sufficient AASV.Methods and analysis This is a multicentre, prospective, controlled, exploratory clinical study in 1150 patients with a medical indication for EVLA of a refluxing great saphenous vein. Patients will be enrolled into two study groups: in half of the patients EVLA will be performed on the insufficient GSV only. In the other half of the patients EVLA will be performed on the insufficient GSV and additionally on the sufficient AASV. Within seven study visits, patients will be followed-up over a time period of 5 years. Primary study endpoint is the recurrence rate; secondary endpoints include inter alia, complication rate, postoperative pain intensity, quality of life and patient satisfaction.Ethics and dissemination Before initiation of the study, the protocol was presented and approved by the independent ethics committee of the medical faculty of the University of Heidelberg (Ethics approval number S-596/2018). This study was prospectively registered at the German Clinical Trial Register (https://www.germanctr.de/). Research findings will be disseminated in a peer-reviewed journal and at relevant conferences.Trial registration number German Clinical Trial Registry (DRKS00015486).https://bmjopen.bmj.com/content/12/6/e061530.full
spellingShingle Lorenz Uhlmann
Christine Fink
Karsten Hartmann
Thomas Mattausch
Hans-Christian Wenzel
Phillip Zollmann
Jürgen Veltman
Thomas Weiler
Guido Lengfellner
Lars Müller
Markus Stücker
Felizitas Pannier
Carmen Dietrich
Tobias Hirsch
Impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein (SYNCHRONOUS-Study): study protocol for a prospective, multicentre, controlled observational study
BMJ Open
title Impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein (SYNCHRONOUS-Study): study protocol for a prospective, multicentre, controlled observational study
title_full Impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein (SYNCHRONOUS-Study): study protocol for a prospective, multicentre, controlled observational study
title_fullStr Impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein (SYNCHRONOUS-Study): study protocol for a prospective, multicentre, controlled observational study
title_full_unstemmed Impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein (SYNCHRONOUS-Study): study protocol for a prospective, multicentre, controlled observational study
title_short Impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein (SYNCHRONOUS-Study): study protocol for a prospective, multicentre, controlled observational study
title_sort impact of a synchronous prophylactic treatment of the anterior accessory saphenous vein on the recurrent varicose vein rate in patients undergoing thermal ablation of an insufficient great saphenous vein synchronous study study protocol for a prospective multicentre controlled observational study
url https://bmjopen.bmj.com/content/12/6/e061530.full
work_keys_str_mv AT lorenzuhlmann impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT christinefink impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT karstenhartmann impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT thomasmattausch impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT hanschristianwenzel impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT phillipzollmann impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT jurgenveltman impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT thomasweiler impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT guidolengfellner impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT larsmuller impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT markusstucker impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT felizitaspannier impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT carmendietrich impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst
AT tobiashirsch impactofasynchronousprophylactictreatmentoftheanterioraccessorysaphenousveinontherecurrentvaricoseveinrateinpatientsundergoingthermalablationofaninsufficientgreatsaphenousveinsynchronousstudystudyprotocolforaprospectivemulticentrecontrolledobservationalst